Oral Cancer Chemoprevention--The End of EPOC, the Beginning of an Epoch of Molecular Selection.
Bauman, Julie E
Oral Cancer Chemoprevention--The End of EPOC, the Beginning of an Epoch of Molecular Selection. [electronic resource] - JAMA oncology Feb 2016 - 178-9 p. digital
Publication Type: Editorial; Comment
2374-2445
10.1001/jamaoncol.2015.4637 doi
Anticarcinogenic Agents--therapeutic use
Erlotinib Hydrochloride--therapeutic use
Female
Humans
Male
Mouth Neoplasms--prevention & control
Precancerous Conditions--drug therapy
Protein Kinase Inhibitors--therapeutic use
Oral Cancer Chemoprevention--The End of EPOC, the Beginning of an Epoch of Molecular Selection. [electronic resource] - JAMA oncology Feb 2016 - 178-9 p. digital
Publication Type: Editorial; Comment
2374-2445
10.1001/jamaoncol.2015.4637 doi
Anticarcinogenic Agents--therapeutic use
Erlotinib Hydrochloride--therapeutic use
Female
Humans
Male
Mouth Neoplasms--prevention & control
Precancerous Conditions--drug therapy
Protein Kinase Inhibitors--therapeutic use